dronabinol has been researched along with Acute Lymphoid Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akmut, F; Illing, B; Kampa-Schittenhelm, KM; Kanz, L; Salih, HR; Salitzky, O; Schittenhelm, MM | 1 |
| Kaminski, NE; Rao, GK | 1 |
| Abrahamov, A; Mechoulam, R | 1 |
| Fisher, M; Grant, S; Lombard, C; Martin, BR; McKallip, RJ; Nagarkatti, M; Nagarkatti, PS; Ryu, S | 1 |
4 other study(ies) available for dronabinol and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Dronabinol; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2016 |
Induction of intracellular calcium elevation by Delta9-tetrahydrocannabinol in T cells involves TRPC1 channels.
Topics: Analgesics, Non-Narcotic; Calcium; Calcium Signaling; Calcium-Transporting ATPases; Cell Line, Tumor; Dronabinol; Enzyme Inhibitors; Humans; Ion Channel Gating; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C; Receptor, Cannabinoid, CB2; Ryanodine Receptor Calcium Release Channel; T-Lymphocytes; TRPC Cation Channels | 2006 |
An efficient new cannabinoid antiemetic in pediatric oncology.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Dronabinol; Female; Hodgkin Disease; Humans; Infant; Male; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Wilms Tumor | 1995 |
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cannabinoids; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Humans; Leukemia, Lymphoid; Ligands; Mice; Mice, Inbred C57BL; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cannabinoid; Receptors, Drug; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2002 |